{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A Survey of Urologists to understand the current perception and practice in the Management of Urinary tract infection

Survey Questionnaire Form
Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif @if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif @if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

General Questions
  1. Which of the following best describes your approach to diagnosing uncomplicated UTIs? *

  2. What is the most common causative organism for uncomplicated UTI in your experience? *

  3. What percentage of uncomplicated UTI cases receive empirical antibiotic treatment without culture sensitivity? *

  4. What factors influence your choice of antibiotics for UTI management? *
  5. Which antibiotic is most commonly prescribed for uncomplicated UTI in your practice? *

  6. What is the duration of antibiotic therapy for uncomplicated UTI in your clinical practice? *

  7. Under what circumstances do you prescribe Fosfomycin? (Select all that apply) *

  8. How frequently do you prescribe Fosfomycin for the treatment of bacterial prostatitis in your practice? *

  9. How effective do you find Fosfomycin in treating bacterial prostatitis? *

  10. What is your usual dosing regimen and duration when prescribing Fosfomycin for bacterial prostatitis? *
  11. Are you aware of the antimicrobial susceptibility rates of Fosfomycin for E. coli in your region? *

  12. How effective is Fosfomycin against multidrug-resistant uropathogens based on your experience? *

  13. How likely are you to recommend Fosfomycin as first-line therapy for uncomplicated UTI? *

  14. What emerging or new antibiotics do you see as promising options for the treatment of uncomplicated urinary tract infections? *
  15. Do you believe antimicrobial resistance is a significant issue in India? *

  16. How often do you consider antibiotic stewardship principles when prescribing for UTI? *

  17. What is your opinion on restricting extended-spectrum antibiotics to high-risk cases only? *

  18. Do you follow national or international guidelines for UTI management? *

  19. If yes, please specify which guidelines you adhere to:
  20. Can you describe any recent changes in guidelines or clinical practice that have impacted your approach to prescribing antibiotics for uncomplicated UTIs? *
  21. What strategies do you implement for antibiotic stewardship in UTI management? (Select all that apply) *

  22. What are the primary barriers to implementing antibiotic stewardship principles in your practice? *
  23. What changes have you made in prescribing patterns due to rising antimicrobial resistance? *
  24. Which non-antibiotic interventions do you recommend alongside treatment for uncomplicated UTIs? *
  25. Do you educate patients about preventing recurrent UTIs during consultations? *

  26. In your clinical experience, what factors contribute most to the progression from an uncomplicated UTI to recurrent in patients? *
  27. What criteria do you use to identify when an uncomplicated UTI may be evolving into a complicated UTI, and how does this influence your treatment strategy? *
  28. What emerging treatments or interventions do you find promising for preventing recurrence or complications in patients with uncomplicated UTIs? *
  29. How do you stay updated about local antimicrobial resistance patterns? (Select all that apply) *

  30. Do you believe that antibiotic stewardship programs are necessary in urology practice? *

  31. How appealing do you find the key message about using Fosfomycin for UTI management in the promotional material below? *

  32. How impactful do you find the medical communication about the use of Fosfomycin for UTI management in the promotional material below? *